Kerala Ayurveda share price
BSE: 530163Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹139.75.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹171 Cr2,181st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 13 Jul 2026
- 15.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Aug 2026
- −257.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- −24.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 13 Jul 2026
- 5.43
- Volume, BSEVolume. Shares traded on the last trading day.
- 9,945
Results
Consolidated; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 12 Aug
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹33 Crdown 4.44%
- Net profitNet profit. Under it, net profit in the quarter before. A change in per cent is not worked out where either period is a loss or nothing.
- −₹8.08 CrQuarter to Mar 2026: −₹7.40 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- −24.3%
Revenue by year
Net profit by year, a loss in red
- Net profit
- Loss
The years either side of a change of basis do not compare. From the year to Mar 2023, the company's revenue for that year, ₹89 Cr, differs from its quarters added, ₹92 Cr. From the year to Mar 2024, the company's revenue for that year, ₹102 Cr, differs from its quarters added, ₹104 Cr. From the year to Mar 2025, the company's revenue for that year, ₹120 Cr, differs from its quarters added, ₹123 Cr.
| ₹ crore | Sep 2024Filed 15 Nov | Dec 2024Filed 15 Feb | Mar 2025Filed 8 Aug | Jun 2025Filed 14 Nov | Sep 2025Filed 14 Nov | Dec 2025Filed 12 Feb | Mar 2026Filed 13 Jul | Jun 2026Filed 12 Aug |
|---|---|---|---|---|---|---|---|---|
| Revenue | 31.8 | 31.1 | 31.3 | 28.6 | 34.8 | 33.0 | 34.7 | 33.2 |
| Net profit | 3.6 | −2.7 | −15.5 | 2.0 | −6.3 | −4.6 | −7.4 | −8.1 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 11.5% | −8.7% | −49.6% | 7.0% | −18.2% | −13.9% | −21.3% | −24.3% |
The quarters either side of a change of basis do not compare. From the quarter to Mar 2025, the company's revenue for the year to Mar 2025, ₹120 Cr, differs from its quarters added, ₹123 Cr.
Business segments
In the year to Mar 2026 the company reports one business segment, AYURVEDA INDUSTRY, which carries all its revenue.
Valuation
Today, against the company's own history. Not shown, P/E: loss, last twelve months. Not shown, EV/EBITDA: operating loss, last twelve months. Dividend yield is not shown: no dividend in the years on record. Its history crosses a change of basis in the accounts in the years to Mar 2023, Mar 2024 and Mar 2025: days before it are of the company before the change.PE ratio and valuation history
At or below today's level on 56% of 1,803 trading days since Nov 2018.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −55.1% | – | – | 0.0% |
| 3 years | +23.7% | – | – | 0.0% |
| 5 years | +25.2% | – | – | 0.0% |
Peers and competitors
Pharmaceuticals, 216 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Kerala Ayurveda in market cap.
Kerala Ayurveda is not on the chart: it has no P/E today
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Accretion NutravedaANL | 198 | 39.0 | 5.6 | – | – | – | 14.3% | – | 0.00% |
| Bio Medica LaboratoriesBMLL | 188 | 16.1 | – | – | – | – | 44.2% | – | 0.00% |
 Sanjivani ParanteralSANJIVIN | 188 | – | 3.9 | 13.5 | +13.2% | – | – | 20.2% | 0.00% |
 Coral LaboratoriesCORALAB | 177 | 9.2 | 0.8 | 5.8 | −5.4% | +7.2% | 9.4% | 7.6% | 0.40% |
 Brooks LaboratoriesBROOKS | 170 | 12.9 | 1.4 | 29.4 | −7.7% | +550.4% | 12.0% | 3.2% | 0.00% |
 Oxygenta PharmaceuticalOXYGENTAPH | 170 | – | – | – | +20.6% | – | – | −15.1% | 0.00% |
 Achyut HealthcareACHYUT | 168 | – | – | – | – | – | – | – | 0.00% |
 Syschem (India)SYSCHEM | 166 | – | – | – | +59.1% | – | – | 11.7% | 0.00% |
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
21 Oct · Announcement under Regulation 30 (LODR)-Allotment
Sep 2026
29 Sep · Meeting
28 Sep · Meeting
28 Sep · Meeting
22 Sep · Meeting
Kerala Ayurveda share price by year
Each calendar year to 2025.Kerala Ayurveda share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 315.75 | −28.4% | 603.95 | 305.95 |
| 2024 | 440.70 | +65.2% | 440.70 | 252.95 |
| 2023 | 266.75 | +152.1% | 277.45 | 79.28 |
| 2022 | 105.80 | +55.5% | 109.15 | 63.40 |
| 2021 | 68.05 | +37.5% | 78.30 | 47.40 |
| 2020 | 49.50 | +19.0% | 78.15 | 29.55 |
| 2019 | 41.60 | −40.9% | 73.65 | 38.40 |
| 2018 | 70.35 | −33.4% | 103.05 | 56.55 |
| 2017 | 105.65 | +51.3% | 120.75 | 64.55 |
| 2016 | 69.85 | +3.3% | 88.55 | 44.40 |
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 23 Oct 2026 | 139.75 | 139.75 | 130.00 | 131.25 | 132.31 | 9,945 |
| 22 Oct 2026 | 139.65 | 141.95 | 139.25 | 139.75 | 140.11 | 4,652 |
| 21 Oct 2026 | 148.00 | 148.00 | 141.00 | 141.45 | 141.69 | 22,446 |
| 19 Oct 2026 | 142.45 | 147.45 | 141.40 | 146.55 | 146.30 | 16,485 |
| 16 Oct 2026 | 147.00 | 148.70 | 146.00 | 146.25 | 147.05 | 3,380 |
| 15 Oct 2026 | 149.95 | 153.90 | 143.25 | 147.00 | 147.03 | 10,505 |
| 14 Oct 2026 | 154.90 | 154.90 | 141.95 | 145.75 | 144.99 | 19,896 |
| 13 Oct 2026 | 150.35 | 154.80 | 148.00 | 148.90 | 150.35 | 3,370 |
| 12 Oct 2026 | 155.00 | 155.00 | 149.95 | 150.50 | 150.65 | 21,946 |
| 9 Oct 2026 | 149.30 | 153.85 | 147.10 | 153.20 | 151.03 | 26,049 |
Company details
- Legal name
- Kerala Ayurveda Limited
- BSE code
- 530163
- ISIN
- INE817B01025
- Industry
- Pharmaceuticals & Biotechnology
- Listed
- May 1995
- Face value
- ₹10
- CIN
- L24233KL1992PLC006592
- Corporate identity number, the registrar of companies' code for it